WASHINGTON, Sept 9 (Reuters) - The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday. The FDA plans to enforce regulations stipulating that drug ads not create a misleading impression...

Sept 9 (Reuters) - * KLARNA, BACKERS RAISE $1.37 BILLION IN US IPO PRICED ABOVE RANGE- BLOOMBERG NEWS * KLARNA GROUP AND SOME OF ITS BACKERS SOLD 34.3 MILLION SHARES FOR $40 PER SHARE-BLOOMBERG NEWS Source: https://tinyurl.com/7933a5tx Further company coverage: ...

WASHINGTON (Reuters) -The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply with regulations that are already on the books, senior administration officials said on Tuesday. The FDA plans to enforce regulations stipulating that drug ads not create a misleading impression about the products...

* Trump signs presidential memorandum on drug ad transparency * Administration seeks to enforce regulations on misleading drug ads * FDA to issue 100 cease-and-desist notices for non-compliant ads * Industry says direct-to-consumer ads help patients (Adds Kennedy quote in paragraph 5, PhRMA response in 6-7) By Michael Erman, Jeff Mason and Ahmed Aboulenein WASHINGTON, Sept 9 (Reuters) - The...